Alexion Pharmaceuticals
Boston, US · 3 known investors
Alexion is a biopharmaceutical company focused on research and development of treatments for rare diseases, serving rare disease patients and their families worldwide.
Investors · 3
Competitors · 2
by search overlapJohnson & Johnson124 shared keywordsJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Regeneron NASDAQ: REGN www.regeneron.com106 shared keywordsRegeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.
Companies competing with Alexion Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Acquisitions · 2
Early investors' stakes continue via these dealsSynageva BioPharma Corp.
Developed therapies for rare conditions with unmet medical needs; exited via IPO and acquired by Alexion Pharmaceuticals.
Syntimmune
Acquired by Alexion Pharmaceuticals
Frequently asked questions
- What does Alexion Pharmaceuticals do?
- Alexion is a biopharmaceutical company focused on research and development of treatments for rare diseases, serving rare disease patients and their families worldwide.
- Who are Alexion Pharmaceuticals's investors?
- Alexion Pharmaceuticals's investors include Andera Partners, Connecticut Innovations, venBio Partners.
- Where is Alexion Pharmaceuticals headquartered?
- Alexion Pharmaceuticals is headquartered in Boston, US.